Zobrazeno 1 - 10
of 647
pro vyhledávání: '"Takekita, Y."'
Autor:
Takekita Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan., Matsumoto Y; Medical Science, Sumitomo Pharma Co., Ltd, Osaka, Japan., Masuda T; Medical Science, Sumitomo Pharma Co., Ltd, Osaka, Japan., Yoshida K; Data Science, Sumitomo Pharma Co., Ltd, Tokyo, Japan., Koshikawa Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan., Kato M; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan.
Publikováno v:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Dec; Vol. 44 (4), pp. 784-791. Date of Electronic Publication: 2024 Oct 20.
Autor:
Aoki N; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, 570-8506, Japan.; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, 2031, Australia.; Black Dog Institute, Sydney, NSW, 2031, Australia., Tajika A; Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, 606-8501, Japan., Suwa T; Department of Neuropsychiatry, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan., Kawashima H; Department of Neuropsychiatry, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan., Yasuda K; Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine, Yamanashi, 409-3898, Japan., Shimizu T; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, 570-8506, Japan., Uchinuma N; Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine, Yamanashi, 409-3898, Japan., Tominaga H; Department of Psychiatry, Mojimatsugae Hospital, Fukuoka, 800-0112, Japan., Tan XW; Department of Mood and Anxiety, Institute of Mental Health, 539747, Singapore., Koh AHK; Department of Mood and Anxiety, Institute of Mental Health, 539747, Singapore., Tor PC; Department of Mood and Anxiety, Institute of Mental Health, 539747, Singapore., Nikolin S; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, 2031, Australia.; Black Dog Institute, Sydney, NSW, 2031, Australia., Martin D; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, 2031, Australia.; Black Dog Institute, Sydney, NSW, 2031, Australia., Kato M; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, 570-8506, Japan., Loo C; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, 2031, Australia.; Black Dog Institute, Sydney, NSW, 2031, Australia., Kinoshita T; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, 570-8506, Japan., Furukawa TA; Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, 606-8501, Japan., Takekita Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, 570-8506, Japan.
Publikováno v:
Schizophrenia bulletin [Schizophr Bull] 2024 Oct 04. Date of Electronic Publication: 2024 Oct 04.
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 16, Pp 2871-2879 (2020)
Yoshiteru Takekita,1 Sachie Inoue,2 Kenji Baba,3 Tadashi Nosaka3 1Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan; 2CRECON Medical Assessment Inc, Tokyo, Japan; 3Sumitomo Dainippon Pharma Co, Ltd, Tokyo, JapanCorrespondence: Yo
Externí odkaz:
https://doaj.org/article/facb9395090b4b5c94944051b042d270
Autor:
Kato M; Department of Neuropsychiatry, Kansai Medical University, 2-3-1 Shin-Machi Hirakata-City, Osaka, 573-1191, Japan. katom@takii.kmu.ac.jp., Baba H; Department of Psychiatry, Faculty of Medicine, Juntendo Koshigaya Hospital, Juntendo University, Saitama, Japan., Takekita Y; Department of Neuropsychiatry, Kansai Medical University, 2-3-1 Shin-Machi Hirakata-City, Osaka, 573-1191, Japan., Naito M; Department of Neuropsychiatry, Kansai Medical University, 2-3-1 Shin-Machi Hirakata-City, Osaka, 573-1191, Japan., Koshikawa Y; Department of Neuropsychiatry, Kansai Medical University, 2-3-1 Shin-Machi Hirakata-City, Osaka, 573-1191, Japan., Bandou H; Seishokai Sephiroth Hospital, Nagahama, Shiga, Japan., Kinoshita T; Department of Neuropsychiatry, Kansai Medical University, 2-3-1 Shin-Machi Hirakata-City, Osaka, 573-1191, Japan.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2023 Nov; Vol. 79 (11), pp. 1515-1524. Date of Electronic Publication: 2023 Sep 13.
Autor:
Murase Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan., Kato M; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan., Kinoshita T; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan., Takekita Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan.
Publikováno v:
The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa [S Afr J Psychiatr] 2024 Sep 26; Vol. 30, pp. 2314. Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024).
Autor:
Nakatake R; Department of Hepato-Biliary-Pancreatic Surgery, Kansai Medical University Medical Center, 10-15 Fumizono-Cho, Moriguchi, Osaka, 573-1010, Japan. nakatakr@hirakata.kmu.ac.jp.; Department of Pancreatobiliary Surgery, Kansai Medical University, 2-5-1 Shin-Machiachi, Hirakata, Osaka, 573-1010, Japan. nakatakr@hirakata.kmu.ac.jp., Funatsuki T; Department of Neuropsychiatry, Kansai Medical University, 10-15 Fumizono-Cho, Moriguchi, Osaka, 573-1010, Japan., Koshikawa Y; Department of Neuropsychiatry, Kansai Medical University, 10-15 Fumizono-Cho, Moriguchi, Osaka, 573-1010, Japan., Okuyama T; Department of Pancreatobiliary Surgery, Kansai Medical University, 2-5-1 Shin-Machiachi, Hirakata, Osaka, 573-1010, Japan., Ishizaki M; Department of Hepato-Biliary-Pancreatic Surgery, Kansai Medical University Medical Center, 10-15 Fumizono-Cho, Moriguchi, Osaka, 573-1010, Japan., Takekita Y; Department of Neuropsychiatry, Kansai Medical University, 10-15 Fumizono-Cho, Moriguchi, Osaka, 573-1010, Japan., Kato M; Department of Neuropsychiatry, Kansai Medical University, 10-15 Fumizono-Cho, Moriguchi, Osaka, 573-1010, Japan., Kitade H; Department of Hepato-Biliary-Pancreatic Surgery, Kansai Medical University Medical Center, 10-15 Fumizono-Cho, Moriguchi, Osaka, 573-1010, Japan.; Department of Pancreatobiliary Surgery, Kansai Medical University, 2-5-1 Shin-Machiachi, Hirakata, Osaka, 573-1010, Japan.
Publikováno v:
Scientific reports [Sci Rep] 2024 Sep 17; Vol. 14 (1), pp. 21704. Date of Electronic Publication: 2024 Sep 17.
Autor:
Takekita Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan. takekity@takii.kmu.ac.jp., Hiraoka S; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Iwama Y; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Matsui D; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Aoki N; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan.; School of Psychiatry, University of New South Wales, Randwick, NSW, Australia.; Black Dog Institute, Randwick, NSW, Australia., Ogata H; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan., Funatsuki T; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan., Shimizu T; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan., Murase Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan., Shimamoto Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan., Koshikawa Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan., Kato M; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan.
Publikováno v:
Annals of general psychiatry [Ann Gen Psychiatry] 2024 Aug 02; Vol. 23 (1), pp. 29. Date of Electronic Publication: 2024 Aug 02.
Autor:
Takekita Y; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Hiraoka S; Medical Affairs Department, Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Iwama Y; Regulatory & Datascience Department, Pharmaceutical Research & Development Division, Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Matsui D; Safety Vigilance & Management Department, Reliability & Quality Assurance Division, Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Aoki N; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.; School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia.; Black Dog Institute, Randwick, New South Wales, Australia., Ogata H; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Funatsuki T; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Shimizu T; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Murase Y; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Koshikawa Y; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Kato M; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Kinoshita T; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
Publikováno v:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Mar; Vol. 44 (1), pp. 234-239. Date of Electronic Publication: 2023 Nov 05.
Autor:
Ogata H; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Higasa K; Institute of Biomedical Science, Department of Genome Analysis, Kansai Medical University, Osaka, Japan., Kageyama Y; Department of Neuropsychiatry, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan., Tahara H; Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan., Shimamoto A; Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Sanyo Onoda, Yamaguchi, Japan., Takekita Y; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Koshikawa Y; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Nonen S; Department of Pharmacy, Hyogo University of Health Sciences, Hyogo, Japan., Kato T; Department of Psychiatry & Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kinoshita T; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Kato M; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan. Electronic address: katom@takii.kmu.ac.jp.
Publikováno v:
Journal of affective disorders [J Affect Disord] 2023 Oct 15; Vol. 339, pp. 538-546. Date of Electronic Publication: 2023 Jul 17.
Autor:
Koshikawa Y; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Onohara A; Social Welfare Corporation Uminoko Gakuen Ikejimaryo, Osaka, Japan., Wakeno M; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Takekita Y; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Kinoshita T; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan., Kato M; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
Publikováno v:
Heliyon [Heliyon] 2023 Oct 13; Vol. 9 (10), pp. e20917. Date of Electronic Publication: 2023 Oct 13 (Print Publication: 2023).